Abstract

BackgroundGallstones and kidney stones are known complications of inflammatory bowel diseases (IBD). Risk factors have been insufficiently studied and explanatory studies date back up to 30 years. It remains unclear, whether improved treatment options also influenced risk factors for these complications.ObjectivesIdentifying risk factors for gallstones and kidney stones in IBD patients.MethodsUsing data from the Swiss Inflammatory Bowel Disease Cohort Study we assessed associations of diseases characteristics with gallstones and kidney stones in univariate and multivariate logistic regression analyses.ResultsOut of 2323 IBD patients, 104 (7.8%) Crohn’s disease (CD) and 38 (3.8%) ulcerative colitis (UC) patients were diagnosed with gallstones. Significant risk factors for gallstones were diagnosis of CD, age at diagnosis, disease activity and duration, NSAID intake, extra-intestinal manifestations and intestinal surgery. Kidney stones were described in 61 (4.6%) CD and 30 (3.0%) UC patients. Male gender, disease activity, intestinal surgery, NSAID usage and reduced physical activity were significant risk factors. Hospitalization was associated with gallstones and kidney stones. The presence of gallstones increased the risk for kidney stones (OR 4.87, p<0.001).ConclusionThe diagnosis of CD, intestinal surgery, prolonged NSAID use, disease activity and duration and bowel stenosis were significantly associated with cholecystonephrolithiasis in IBD.

Highlights

  • Inflammatory bowel diseases (IBD) comprise chronic inflammatory diseases of the gastrointestinal tract (GIT), including Crohn’s disease (CD), ulcerative colitis (UC) and indeterminate colitis (IC)

  • Out of 2323 inflammatory bowel diseases (IBD) patients, 104 (7.8%) Crohn’s disease (CD) and 38 (3.8%) ulcerative colitis (UC) patients were diagnosed with gallstones

  • The diagnosis of CD, intestinal surgery, prolonged Nonsteroidal anti-inflammatory drugs (NSAID) use, disease activity and duration and bowel stenosis were significantly associated with cholecystonephrolithiasis in IBD

Read more

Summary

Introduction

Inflammatory bowel diseases (IBD) comprise chronic inflammatory diseases of the gastrointestinal tract (GIT), including Crohn’s disease (CD), ulcerative colitis (UC) and indeterminate colitis (IC). The diseases are associated with lifelong morbidity and increased mortality [1, 2]. Patients suffer from extraintestinal complications of IBD. An increased risk of gallstone disease in CD patients is well established [3,4,5,6,7,8,9]. Gallstones and kidney stones are known complications of inflammatory bowel diseases (IBD). Risk factors have been insufficiently studied and explanatory studies date back up to 30 years. It remains unclear, whether improved treatment options influenced risk factors for these complications

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call